538964 — MERCURY LABORATORIES Income Statement
0.000.00%
Last trade - 00:00
- IN₹1.20bn
- IN₹1.17bn
- IN₹755.59m
- 72
- 27
- 49
- 47
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 573 | 686 | 579 | 753 | 756 |
Cost of Revenue | |||||
Gross Profit | 316 | 374 | 343 | 449 | 453 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 530 | 609 | 534 | 692 | 693 |
Operating Profit | 43 | 76.7 | 45.4 | 60.9 | 62.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 43.3 | 79.1 | 50.3 | 74.9 | 69.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 32.3 | 53.4 | 35.6 | 55.8 | 56.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 32.3 | 53.4 | 35.6 | 55.8 | 56.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 32.3 | 53.4 | 35.6 | 55.8 | 56.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 31.9 | 51.4 | 29.7 | 46.5 | 47.1 |
Dividends per Share |